DLH disposes of Russian and Brazilian company and will make

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
DLH disposes of Russian and Brazilian company and will make use of its option to purchase the former HQ office building in Hoeje Taastrup

DLH has entered into an agreement with the local management about sale of the Russian company. The transaction is expected to take place end of April 2015 and results in a loss of DKK 7 million and will yield proceeds at DKK 4 million. Provisions for the loss of DKK 7 million have been made in the Annual Accounts for 4th quarter 2014.

Furthermore, DLH has entered into an agreement about sale of the Group’s Brazilian company.  This company does not include operating activities but holds among others a minor forest and a few outstanding receivables. The transaction is expected to yield approx. DKK 2 million.

After these divestments, DLH’s only remaining asset in Brazil will be a 5.6 per cent share­holding in the company Caceres Florestal that operates a teak plantation.

The only operating companies left within the Group are hereafter DLH’s Nordic sheet business in Denmark and Sweden and the French hardwood company, DLH France.

DLH will make use of its option to purchase the former head quarter office building located at Skagensgade in Hoeje Taastrup

The domicile that DLH vacated in the summer of 2013 has been put up for sale for the past couple of years. DLH has a lease commitment on the property expiring in 2027, but has now chosen to make use of its option to purchase the property. According to the lease agreement entered in 2007 the purchase price amounts DKK 54 million and will be financed by raising of bank loan. By finalizing this purchase, the future lease commitments will cease and going forward will give an annual cost saving in relation to the lease expenses in the level of just under DKK 2 million.

The property continues to be for sale.

In 4th quarter 2014 provisions for expected loss and various costs totaling DKK 8 million have been made. This, combined with previous provisions means that the property will be recognized at a value of DKK 33 million when the transactions has been finalized.

         For further information about this announcement, please contact Kent Arentoft, President &          CEO or Peter Thostrup, CFO, on tel. +45 4350 0101.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Investors Urged to Explore Rights in Symbotic Class Action

Updated Category News Views 77

Understanding the Class Action Lawsuit for Symbotic Inc. Investors in Symbotic Inc. (NASDAQ:SYM) are currently facing significant concerns regarding recent developments within the company. A class action lawsuit has been initiated in the U.S. District Court for the District of Massachusetts, aimed at those investors who purchased securities between the specified dates....

Continue Reading
Egypt's President Sisi Reflects on IMF Agreement Amid Crisis

Updated Category News Views 169

Egypt's Economic Landscape Under Scrutiny In light of unprecedented regional challenges, Egyptian President Abdel Fattah al-Sisi has raised concerns regarding the nation's ongoing agreement with the International Monetary Fund (IMF). The $8 billion financial support program, signed amidst economic turbulence, may be revisited if the expectations of global financial...

Continue Reading
Insights into Mastercard's Recent Options Trading Dynamics

Updated Category News Views 102

Mastercard's Options Activity: What's Happening? Recently, the options market has seen significant movement from large investors, commonly referred to as "whales." This activity indicates a largely bearish sentiment towards Mastercard. In our analysis of the recent trades involving Mastercard MA, we identified eight significant transactions. Interestingly, none of these...

Continue Reading
Coave Therapeutics Raises Significant Funding for Genetic Breakthroughs

Updated Category News Views 292

Coave Therapeutics Secures Major Investment to Propel Innovation Coave Therapeutics, a pioneer in the realm of genetic medicines, has successfully raised €32 million (approximately $33 million) in a Series A financing round. This funding was notably co-led by Novo Holdings A/S and Bpifrance, with additional contributions from leading investors in the US and EU,...

Continue Reading
Strive Expands with MSTR True North Acquisition and Leadership Change

Updated Category News Views 140

Strive's Exciting Acquisition of MSTR True North Inc. Strive, Inc. has made waves in the financial technology sector with its strategic acquisition of MSTR True North Inc. This move marks a pivotal moment in Strive's journey, enhancing its commitment to Bitcoin advocacy and marking a significant step forward in the realm of Digital Capital and Digital Credit. Leadership...

Continue Reading